Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

284
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
284
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

319
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
319
Vascular Spasm01:16

Vascular Spasm

4.7K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.7K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.9K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status in paediatric liver transplantation for inherited metabolic diseases.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Reply to: residual risk after familial RYR1 testing: interpreting malignant hyperthermia susceptibility in the context of regional testing strategies.

European journal of human genetics : EJHG·2026
Same author

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

Journal of inherited metabolic disease·2026
Same author

Pathogenic variants in the autophagy-tethering factor EPG5 drive neurodegeneration through mitochondrial dysfunction and innate immune activation.

Nature communications·2026
Same author

EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders.

European journal of human genetics : EJHG·2026
Same author

The Use of Machine Learning to Enable Objective Assessment of Surgical Outcomes in Sagittal Craniosynostosis.

Plastic and reconstructive surgery. Global open·2026

Related Experiment Video

Updated: Mar 24, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.9K

Vici syndrome: a review.

Susan Byrne1, Carlo Dionisi-Vici2, Luke Smith3

  • 1Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, UK.

Orphanet Journal of Rare Diseases
|March 2, 2016
PubMed
Summary
This summary is machine-generated.

Vici syndrome is a severe congenital disorder caused by EPG5 gene mutations, affecting autophagy. This genetic condition leads to multisystem issues and reduced lifespan, highlighting a need for targeted therapies.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

3.4K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.9K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

3.4K

Area of Science:

  • Genetics
  • Cell Biology
  • Developmental Biology

Background:

  • Vici syndrome is a severe, recessively inherited congenital disorder.
  • Key features include callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immunodeficiency.
  • Patients exhibit developmental delay, failure to thrive, and microcephaly, suggesting neurodegeneration.

Purpose of the Study:

  • To describe the genetic basis and clinical spectrum of Vici syndrome.
  • To elucidate the role of EPG5 in autophagy and its dysfunction in Vici syndrome.
  • To differentiate Vici syndrome from other genetic and neurological disorders.

Main Methods:

  • Genetic analysis of mutations in the EPG5 gene.
  • Clinical evaluation of patients with Vici syndrome.
  • Review of existing literature on Vici syndrome and autophagy.

Main Results:

  • Vici syndrome is caused by recessive mutations in the EPG5 gene, which encodes a key autophagy regulator.
  • Approximately 40 EPG5 mutations have been identified, mostly truncating.
  • Consistent skeletal myopathy with specific histological features is observed.

Conclusions:

  • Vici syndrome represents a congenital disorder of autophagy due to EPG5 mutations.
  • Understanding the autophagy defect is crucial for developing future targeted therapies.
  • Early diagnosis and supportive management are essential given the reduced life expectancy.